External Certifications
Preferred BreederHealth Testing: Canine Multiple System Degeneration, Kerry Blue Terrier Type, Polyneuropathy, Greyhound Type (NDRG1), Full Embark Panel, Myotonia Congenita, Australian Cattle Dog Type, Myotubular Myopathy, Labrador Retriever Type, Inherited Myopathy in Great Danes (IMGD), Duchenne Muscular Dystrophy, Golden Retriever Type, Duchenne Muscular Dystrophy, Pembroke Welsh Corgi Type, Cavalier King Charles Spaniel Muscular Dystrophy (CKCS-MD), Juvenile Dilated Cardiomyopathy, Long QT Syndrome, Dilated Cardiomyopathy 2 (DCM2), Dilated Cardiomyopathy 1 (DCM1), Juvenile Myoclonic Epilepsy (JME), Polyneuropathy 2, Leonberger and Saint Bernard Type, Polyneuropathy 1, Leonberger and Saint Bernard Type, Acral Mutilation Syndrome (AMS), Juvenile Laryngeal Paralysis & Polyneuropathy (JLPP), Multiple System Degeneration, Chinese Crested Type, L-2-Hydroxyglutaric Aciduria (L2HGA), Staffordshire Bull Terrier Type, Narcolepsy, Dachshund Type, Narcolepsy, Labrador Retriever Type, Neuroaxonal Dystrophy (NAD), Spanish Water Dog Type, Neuroaxonal Dystrophy (NAD), Rottweiler Type, X-Linked Tremors, Shaking Puppy Syndrome (SPS), Hypomyelination, Weimaraner Type, Benign Familial Juvenile Epilepsy (BFJE), Spinocerebellar Ataxia (SCA), Late Onset Ataxia, Spinocerebellar Ataxia (LOA, SCA), Cerebellar Ataxia, Finnish Hound Type, Neonatal Cortical Cerebellar Degeneration (NCCD), Alexander Disease, Encephalopathy, Alaskan Husky Type, Persistent Müllerian Duct Syndrome, Familial Enamel Hypoplasia (FEH), Italian Greyhound Type, Globoid Cell Leukodystrophy (GCL), Terrier Type, GM1 Gangliosidosis, Portuguese Water Dog Type, GM1 Gangliosidosis (HEXB), Shiba Inu Type, GM1 Gangliosidosis (GLB1), Shiba Inu Type, GM1 Gangliosidosis, Alaskan Husky Type, Gangliosidosis GM2, Japanese Chin Type, Neuronal Ceroid Lipofuscinosis, Tibetan Terrier Type, Neuronal Ceroid Lipofuscinosis 12 (NCL12), Australian Cattle Dog Type, Neuronal Ceroid Lipofuscinosis 8 (NCL8), Setter Type, Neuronal Ceroid Lipofuscinosis 6 (NCL 6), Neuronal Ceroid Lipofuscinosis 5 (NCL5), Golden Retriever Type, Neuronal Ceroid Lipofuscinosis 5 (NCL5), Border Collie Type, Neuronal Ceroid Lipofuscinosis 2 (NCL2), Neuronal Ceroid Lipofuscinosis 1 (NCL1), Dachshund Type, Neuronal Ceroid Lipofuscinosis 10 (NCL10), American Bulldog Type, Lagotto Storage Disease (LSD), Neuronal Ceroid Lipofuscinosis 1 (NCL1), Cane Corso Type, Mucopolysaccharidosis VII (MPS VII), Brazilian Terrier Type, Mucopolysaccharidosis VII (MPS VII ARSB), German Shepherd Dog Type, Mucopolysaccharidosis IIIA (MPS IIIA), New Zealand Huntaway Type, Mucopolysaccharidosis IIIA (MPS IIIA), Dachshund Type, Glycogen Storage Disease Type IIIA, GSD IIIA, Glycogen Storage Disease Type II or Pompe's Disease (GSD II), Fucosidosis, Renal Cystadenocarcinoma and Nodular Dermatofibrosis (RCND), Ectodermal Dysplasia, Chesapeake Bay Retriever Type, Dry Eye Curly Coat Syndrome (CKSID), Familial Nephropathy, Cocker Spaniel Type, Protein-Losing Nephropathy (PLN; NPHS1 Gene Variant), Calcium Oxalate Urinary Stones (Research), Polycystic Kidney Disease (PKD), Cystinuria Type II-B, Miniature Pinscher Type, Cystinuria Type II-A, Australian Cattle Dog Type, Cystinuria Type 1A, Newfoundland Type, Cystinuria Type 1A, Labrador Retriever Type, Congenital Stationary Night Blindness (CSNB), Primary Lens Luxation (PLL), Primary Open Angle Glaucoma and Primary Lens Luxation (POAG/PLL), Shar-Pei Type, Primary Open Angle Glaucoma (ADAMST10 Exon 17), Primary Open Angle Glaucoma (ADAMST17 Exon 11), Gondysgenesis and Glaucoma, Border Collie Type, Glaucoma (BCG), Border Collie Type, Multifocal Retinopathy 3 (CMR3), Multifocal Retinopathy 2 (CMR2), Multifocal Retinopathy 1 (CMR1), Coton de Tulear Type, Multifocal Retinopathy 1 (CMR1), Day Blindness, Achromatopsia, Cone Degeneration, German Shorthaired Pointer Type, Collie Eye Anomaly (CEA), PRA, Shetland Sheepdog Type, PRA (PRA1), Papillon Type, PRA, Irish Setter Type, PRA, Golden Retriever 2, PRA, Golden Retriever 1, Early Onset Progressive Retinal Atrophy (EOPRA), Severe Combined Immunodeficiency Disease, X-Linked (XSCID), Corgi Type, Severe Combined Immunodeficiency Disease, Terrier Type, Severe Combined Immunodeficiency Disease, Frisian Water Dog Type, Severe Combined Immunodeficiency Disease, X-Linked, Basset Hound Type (XSCID), Compliment 3 Deficiency (C3), Congenital Hypothyroidism with Goiter, Terrier Type (CHG), Congenital Methemoglobinemia, Pomeranian Type, Canine Scott Syndrome (CSS), Trapped Neutrophil Syndrome, Cohen Syndrome (TNS), Pyruvate Kinase Deficiency (PKD), Terrier Type, Pyruvate Kinase Deficiency (PKD), Pug Type, Pyruvate Kinase Deficiency (PKD), Labrador Retriever Type, Pyruvate Kinase Deficiency (PKD), Cairn Terrier Type, Pyruvate Kinase Deficiency (PKD), Beagle Type, Pyruvate Kinase Deficiency, Basenji Type (PKD), Pyruvate Dehydrogenase Phosphatase 1 Deficiency (PDP1), Prekallikrein Deficiency, Fletcher Trait, May-Hegglin Anomaly, Glanzmann's Thrombasthenia, Otterhound Type, Elliptocytosis, Congenital Macrothrombocytopenia, Leukocyte Adhesion Deficiency, Type III, Leukocyte Adhesion Deficiency, Type I, Chondrodystrophy and IVDD Risk (CDDY-IVDD), Craniomandibular Osteopathy (CMO), Skeletal Dysplasia (SD2), Osteogenesis Imperfecta (OI), Golden Retriever Type, Osteogenesis Imperfecta (OI), Dachshund Type, Hereditary Vitamin D-Resistant Rickets (HVDRR), Cleft Palate (ADAMTS20), Ehlers-Danlos Syndrome, Lethal Acrodermatitis (LAD), Bull Terrier Type, Musladin-Leuke Syndrome (MLS), Hereditary Nasal Parakeratosis (HNPK), Ichthyosis (KRY10), Ichthyosis, Great Dane Type, Ichthyosis, Golden Retriever Type 1, Ichthyosis, American Bulldog Type, Episodic Falling Syndrome (EFS), Adult Paroxysmal Dyskinesia, Intestinal Cobalamin Malabsorption (IGS CUBN Exon 8), Border Collie Type, Intestinal Cobalamin Malabsorption (IGS CUBN Exon 53), Border Collie Type, Malignant Hyperthermia (MH), Hypocatalasia, Myotonia Congenita, Schnauzer Type, von Willebrand Disease III (vWD III), Shetland Sheepdog Type, von Willebrand Disease III (vWD III), Kooikerhondje Type, von Willebrand Disease III (vWD III), Scottish Terrier Type, von Willebrand Disease III (vWD III), Thrombopathia, Newfoundland Type, Factor VII Deficiency, P2RY12 Receptor Platelet Disorder, Osteochondrodysplasia, Miniature Poodle Type, Neonatal Encephalopathy with Seizures (NEwS), Degenerative Myelopathy (DM; SOD1A), Hereditary Ataxia, Cerebellar Ataxia, GM2 Gangliosidosis, Poodle Type, Primary Ciliary Dyskinesia, Kartagner Syndrome (PCD), Progressive Retinal Atrophy (PRA), Generalized, von Willebrand Disease I (vWD I), Multiple Drug Sensitivity (MDR1), Exercise Induced Collapse (EIC), PRA, Rod-Cone Degeneration (PRA-prcd)